Not Signed In -
Melanoma, Intraocular |
Eye |
For other uses, see Eye (disambiguation). Closeup of a blue-green human eye. An eye is an organ of vision that detects light. Different kinds of light-sensitive organs are found in a variety of organisms. The simplest eyes do nothing but detect whether the surroundings are light or dark, while more complex eyes can distinguish shapes and colors. Many animals, including some mammals, birds, reptiles and fish, have two eyes which may be placed on the same plane to be interpreted as a ...
Wikipedia - [full article]
Melanoma, Intraocular Clinical Trials
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003339 - Active, not recruiting
Stage IV Melanoma; recurrent intraocular melanoma; stage III melanoma; Recurrent Melanoma
- Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00005815 - Active, not recruiting
intraocular melanoma; Melanoma
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00072345 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
intraocular melanoma; Melanoma
- AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00243061 - Recruiting
Intraocular Melanoma; Melanoma
- Suberoylanilide Hydroxamic Acid in Treating Patients with Metastatic Or Unresectable Melanoma
ClinicalTrials.gov Identifier: NCT00121225 - Recruiting
Recurrent Melanoma; Stage IV Melanoma; recurrent intraocular melanoma; iris melanoma; extraocular extension melanoma; ...
- Temozolomide and Interferon alfa in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00027742 - Active, not recruiting
iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00288041 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00334776 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00238329 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- Lenalidomide in Treating Patients With Stage IV Eye Melanoma
ClinicalTrials.gov Identifier: NCT00112606 - Recruiting
ciliary body and choroid melanoma, medium/large size; extraocular extension melanoma; iris melanoma; recurrent intraocular melanoma
- Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation
ClinicalTrials.gov Identifier: NCT00471133 - Recruiting
Melanoma (Skin); Intraocular Melanoma
- Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00313508 - Recruiting
Intraocular Melanoma; Melanoma (Skin)
- Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00084656 - Recruiting
intraocular melanoma; Melanoma
- Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
ClinicalTrials.gov Identifier: NCT00110123 - Recruiting
liver metastases; ciliary body and choroid melanoma, medium/large size; iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma
- Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
ClinicalTrials.gov Identifier: NCT00324727 - Recruiting
Intraocular Melanoma; Melanoma (Skin); Metastatic Cancer
- VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00450255 - Recruiting
Intraocular Melanoma; Melanoma (Skin)
- Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
ClinicalTrials.gov Identifier: NCT00329641 - Recruiting
Intraocular Melanoma
- Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
ClinicalTrials.gov Identifier: NCT00489944 - Recruiting
Intraocular Melanoma
- Genetic and Clinical Study of Patients With Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
ClinicalTrials.gov Identifier: NCT00004044 - Recruiting
Head and Neck Cancer; Intraocular Melanoma; Melanoma (Skin); Non-Melanomatous Skin Cancer; Precancerous/Nonmalignant Condition
- Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
ClinicalTrials.gov Identifier: NCT00482911 - Recruiting
Intraocular Melanoma; Malignant Conjunctival Neoplasm
- Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00398073 - Recruiting
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00471471 - Not yet recruiting
Intraocular Melanoma; Malignant Conjunctival Neoplasm; Melanoma (Skin)
- Isolated Hepatic (Liver) Perfusion With Melphalan Followed By Temozolomide in Treating Patients With Unresectable Liver Metastases From Ocular (Eye) Melanoma
ClinicalTrials.gov Identifier: NCT00066521 - Recruiting
Intraocular Melanoma; Metastatic Cancer
- Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
ClinicalTrials.gov Identifier: NCT00003802 - Completed
ciliary body and choroid melanoma, medium/large size; Stage IV Melanoma; extraocular extension melanoma; recurrent intraocular melanoma; ...
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00005841 - Completed
ciliary body and choroid melanoma, medium/large size; Stage IV Melanoma; extraocular extension melanoma; recurrent intraocular melanoma; ...
- Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00058279 - Completed
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
ClinicalTrials.gov Identifier: NCT00020475 - Completed
Extraocular Extension Melanoma; Recurrent Intraocular Melanoma
- Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00004153 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00032045 - Completed
Intraocular Melanoma; Melanoma (Skin)
- Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00031733 - Completed
intraocular melanoma; Melanoma
- Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00301067 - Suspended
Intraocular Melanoma; Melanoma (Skin)
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
ClinicalTrials.gov Identifier: NCT00445965 - Recruiting
Brain and Central Nervous System Tumors; Intraocular Melanoma; Lung Cancer; Melanoma (Skin); Metastatic Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma; Small Intestine Cancer
- PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00004152 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00005633 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma
ClinicalTrials.gov Identifier: NCT00002973 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00016263 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Interferon beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
ClinicalTrials.gov Identifier: NCT00085306 - Completed
Recurrent Melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; extraocular extension melanoma; ...
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00052988 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- Vaccine Therapy With Immune Adjuvant in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00085137 - Active, not recruiting
Recurrent Melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089193 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00003897 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Boron Neutron Capture Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00059800 - Active, not recruiting
Recurrent Melanoma; stage 0 melanoma; stage I melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
- Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002781 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00081042 - Active, not recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
ClinicalTrials.gov Identifier: NCT00089063 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ...
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003552 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003646 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003346 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00007969 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002817 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00004184 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Intraocular Pressure During Abdominal Aortic Aneurysm Repair
ClinicalTrials.gov Identifier: NCT00450294 - Recruiting
Perioperative Blindness; Intraocular Pressure; Ischemic Optic Neuropathy
- Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00104845 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00037037 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
ClinicalTrials.gov Identifier: NCT00070343 - Active, not recruiting
Stage IV Melanoma; stage III melanoma
- Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
ClinicalTrials.gov Identifier: NCT00049010 - Active, not recruiting
stage I melanoma; stage II melanoma
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00053391 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00066196 - Active, not recruiting
Melanoma; Malignant Metastatic Melanoma
- Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00004141 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00045357 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Tipifarnib in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00060125 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00107159 - Active, not recruiting
Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
- Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
ClinicalTrials.gov Identifier: NCT00079417 - Recruiting
intraocular retinoblastoma
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003222 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy with Or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00118313 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma
- Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002845 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer
ClinicalTrials.gov Identifier: NCT00409669 - Recruiting
Elevated Intraocular Pressure
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Surgery in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002860 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- CCI-779 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00022464 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00087373 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00082875 - Active, not recruiting
stage III melanoma; Stage IV Melanoma
- Peptide Vaccine, Montanide ISA 51, and CpG 7909 in Treating Patients With Resected Stage IIC, Stage III, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00085189 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ...
- Multiepitope Peptide Vaccination in Melanoma
ClinicalTrials.gov Identifier: NCT00153569 - Active, not recruiting
Metastatic Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00022568 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Everolimus in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00098553 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
ClinicalTrials.gov Identifier: NCT00450593 - Recruiting
Hereditary Melanoma 1 and 2 (cdkn2, cdk4); Melanoma (Skin)
- Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003747 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00003556 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Gene Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005943 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00071981 - Recruiting
Stage IV Melanoma; Recurrent Melanoma
- Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00006035 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; Quality of Life
- Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
ClinicalTrials.gov Identifier: NCT00000119 - Active, not recruiting
Cataract; Uveitis
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
ClinicalTrials.gov Identifier: NCT00086866 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003224 - Active, not recruiting
Stage IV Melanoma; stage II melanoma; stage III melanoma; Recurrent Melanoma
- Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
ClinicalTrials.gov Identifier: NCT00017121 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; lung metastases
- Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
Malignant Melanoma
- Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00116597 - Active, not recruiting
Melanoma
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00033228 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer Involving the Central Nervous System
ClinicalTrials.gov Identifier: NCT00068666 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; brain metastases
- Novel Adjuvants for Peptide-Based Melanoma Vaccines
ClinicalTrials.gov Identifier: NCT00028431 - Recruiting
Melanoma
- Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
ClinicalTrials.gov Identifier: NCT00002794 - Active, not recruiting
intraocular retinoblastoma
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
email this page
print this page
bookmark this page
feedback on this page
